Quarterly Activities Report
Melbourne, July 28, 2022 AEST (ABN Newswire) - Bluechiip Limited (
ASX:BCT) (1BL:FRA), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the company's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 June 2022.
ACTIVITIES REPORT FOR THE QUARTER ENDED 30 JUNE 2022
Corporate and Business updates for the Quarter
- Recorded sales of $527k. Total sales for the year were $917k and cash receipts for the quarter were $258k;
- Strong sales conversion in 10 labs across nine active direct customers since the launch of the Bluechiip Enabled range of storage consumables, readers and software in the December quarter;
- Delivery of Bluechiip Enabled Products to Labcon under distribution agreement for delivery to Labcon's customers;
- Strong pipeline building with the expansion of North American Sales and marketing to a team of four;
- Actively executing development activities with FujiFilm Irvine Scientific under the licence and development agreement executed in the December quarter;
- Continued discussions and negotiations with potential OEMs in pursuit of additional OEM partner agreements including delivery of concepts and prototypes to pharmaceutical, cell therapy and biobanking OEM customers;
- Successfully granted a new US Patent: Device, System and Method for Temperature Limit Indication and Detection of Temperature-Sensitive Items;
- Cash refund of $1.09m received for the research and development tax incentive relating to the financial year ended 30 June 2021; and
- Closing cash and cash equivalents of $2.75m as at 30 June 2022, with no borrowings.
*To view the full Quarterly Report, please visit:
https://abnnewswire.net/lnk/ZG75OAM8
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
